{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T13:48:31Z","timestamp":1775742511298,"version":"3.50.1"},"reference-count":31,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,1,5]],"date-time":"2002-01-05T00:00:00Z","timestamp":1010188800000},"content-version":"vor","delay-in-days":1434,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet Pharm &amp; Therapeutics"],"published-print":{"date-parts":[[1998,2]]},"abstract":"<jats:p>The purpose of this study was to determine the concentration of enrofloxacin and its active metabolite, ciprofloxacin, in alveolar macrophages (AM) and epithelial lining fluid (ELF) of the lungs in comparison to plasma concentrations in healthy dogs. Eleven dogs were given a single oral dose (5 mg\/kg) of enrofloxacin. Four hours later, plasma and bronchoalveolar lavage (BAL) fluid were collected. Cells were separated from the BAL fluid and lysed for determination of drug concentrations within AM. Supernatant was used to determine concentrations of drugs in ELF. Drug assays were performed by high\u2010performance liquid chromatography.<\/jats:p><jats:p>\u2003The concentration of enrofloxacin (mean\u2003\u00b1\u2003SD) was 0.33\u2003\u00b1\u20030.14 \u03bcg\/mL in plasma, 3.34\u2003\u00b1\u20032.4 \u03bcg\/mL in AM and 4.79\u2003\u00b1\u20035.0 \u03bcg\/mL in ELF. The concentration of ciprofloxacin was 0.42\u2003\u00b1\u20030.26 \u03bcg\/mL in plasma, 1.15\u2003\u00b1\u20031.03 \u03bcg\/mL in AM and 0.26\u2003\u00b1\u20030.26 \u03bcg\/mL in ELF. Mean concentrations of both drugs in AM were greater than in plasma (AM to plasma ratio, 10.3 for enrofloxacin and 4.7 for ciprofloxacin). Mean concentrations of enrofloxacin, but not ciprofloxacin, in ELF were greater than in plasma (ELF to plasma ratio, 13.5 for enrofloxacin and 0.52 for ciprofloxacin). Enrofloxacin concentrations in AM and ELF largely exceeded the MICs of the major bacterial pathogens and surpassed by about two times the breakpoint MIC of that drug, and ciprofloxacin concentrations in AM surpassed the MIC of many susceptible organisms. These results suggest that sufficient antimicrobial activity is present in AM and ELF of dogs following oral administration of enrofloxacin to be effective in the treatment of lower respiratory tract infections involving susceptible organisms.<\/jats:p>","DOI":"10.1046\/j.1365-2885.1998.00103.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T09:20:27Z","timestamp":1047460827000},"page":"18-23","source":"Crossref","is-referenced-by-count":27,"title":["Concentration of enrofloxacin and its active metabolite in alveolar macrophages and pulmonary epithelial lining fluid of dogs"],"prefix":"10.1111","volume":"21","author":[{"family":"Hawkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Boothe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Guinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Aucoin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ngyuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,4,20]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/30.3.377"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/28.1.79"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1183\/09031936.93.03080886","article-title":"Azithromycin concentrations at the site of pulmonary infection","volume":"3","author":"Baldwin D.R.","year":"1990","journal-title":"European Respiratory Journal"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/26.suppl_B.27"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.9.1312"},{"key":"e_1_2_6_7_2","first-page":"S42","article-title":"Morphometric characteristics of cells in the alveolar region of mammalian lungs","volume":"128","author":"Crapo J.D.","year":"1983","journal-title":"American Review of Respiratory Disease"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.38.4.442"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/16.1.67"},{"key":"e_1_2_6_10_2","unstructured":"Gerding D.N. Peterson L.R. Hughes C.E. Bamberger D.M. Larson T.A.(1991)Extravascular antimicrobial distribution and the respective blood concentrations in humans.InAntibiotics in Laboratory Medicine. 3rd Edn. Ed. Lorian V. pp.880961. Williams & Wilkins Baltimore."},{"key":"e_1_2_6_11_2","unstructured":"Gump D.W.(1996)Antimicrobial susceptibility testing for some atypical microorganisms: Chlamydiae mycoplasmas rickettsia and spirochetes.InAntibiotics in Laboratory Medicine. 4th Edn. Ed. Lorian V. pp.212229. Williams and Wilkins Baltimore."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.27.1.42"},{"key":"e_1_2_6_13_2","first-page":"933","article-title":"Uptake of antibiotics by human alveolar macrophages","volume":"129","author":"Hand W.L.","year":"1984","journal-title":"American Review of Respiratory Disease"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1990.tb03120.x"},{"key":"e_1_2_6_15_2","unstructured":"Inderlied C.B.&Nash K.A.(1996)Antimycobacterial agents: In vitro susceptibility testing spectra of activity mechanisms of action and resistance and assays for activity in biological fluid.InAntibiotics in Laboratory Medicine. 4th Edn. Ed. Lorian V. pp.127175. Williams and Wilkins Baltimore."},{"key":"e_1_2_6_16_2","first-page":"429","article-title":"Antibiotic uptake by alveolar macrophages","volume":"95","author":"Johnson J.D.","year":"1980","journal-title":"The Journal of Laboratory and Clinical Medicine"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1993.tb00212.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1164\/arrd.1987.135.6.1276"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00013542-199510000-00002"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/3.1.67"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1986.60.2.532"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/141.1.208"},{"key":"e_1_2_6_23_2","unstructured":"Schalm O.W. Jain N.C. Carroll E.J.(1975)Veterinary Hematology pp.5859. Lea & Febiger Philadelphia."},{"key":"e_1_2_6_24_2","first-page":"90","article-title":"Studies on the antibacterial activity of Baytril","volume":"2","author":"Scheer M.","year":"1987","journal-title":"Veterinary Medical Review"},{"key":"e_1_2_6_25_2","first-page":"30","article-title":"Kinetics of antibacterial activity after administration of enrofloxacin in dog serum and skin: in vitro susceptibility of field isolates.","volume":"18","author":"Stegemann M.","year":"1996","journal-title":"Compendium on Continuing Education for the Practicing Veterinarian (Supplement)"},{"key":"e_1_2_6_26_2","unstructured":"Thompson A.B. Spurzem J.R. Rennard S.I.(1993)Bronchoalveolar lavage in interstitial lung disease.InInterstitial Lung Disease. Eds Schwarz M.I. & King T.E. pp.119126. Mosby year Book St. Louis."},{"key":"e_1_2_6_27_2","unstructured":"Tulkens P.M.(1990)Accumulation and subcellular distribution of antibiotics in macrophages in relation to activity against intracellular activity.InCiprofloxacin in Pulmonology. Ed. Fass R.J. pp.1220. W. Zuckschwerdt Verlag Munchen San Francisco."},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)82739-5"},{"key":"e_1_2_6_29_2","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.2460\/ajvr.1992.53.12.2315","article-title":"Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs","volume":"53","author":"Walker R.D.","year":"1992","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2257.1987.tb00091.x"},{"key":"e_1_2_6_31_2","unstructured":"Wiedemann B.&Grimm H.(1996)Susceptibility to antibiotics: species incidence and trends.InAntibiotics in Laboratory Medicine. Ed. Lorian V. pp.9001168. Williams and Wilkins Philadelphia."},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/28.suppl_C.65"}],"container-title":["Journal of Veterinary Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2885.1998.00103.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2885.1998.00103.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1365-2885.1998.00103.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2885.1998.00103.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T05:00:10Z","timestamp":1733720410000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2885.1998.00103.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["10.1046\/j.1365-2885.1998.00103.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2885.1998.00103.x","archive":["Portico"],"relation":{},"ISSN":["0140-7783","1365-2885"],"issn-type":[{"value":"0140-7783","type":"print"},{"value":"1365-2885","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,2]]}}}